Differential membrane type 1 matrix metalloproteinase substrate processing with ischemia–reperfusion: Relationship to interstitial microRNA dynamics and.

Slides:



Advertisements
Similar presentations
Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion  Ajay Kher, MD, Kirstan.
Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm.
A wolf in sheep's clothing
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Extracorporeal membrane oxygenation for septic shock: Heroic futility?
Rupak Mukherjee, PhD, Juozas A. Zavadzkas, MD, Stuart M
Effects of small platform catheter-based left ventricular assist device support on regional myocardial signal transduction  Keshava Rajagopal, MD, PhD,
Hemodynamics and myocardial blood flow patterns after placement of a cardiac passive restraint device in a model of dilated cardiomyopathy  Jennifer A.
Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats 
How do cells talk to each other
Jeffrey A. Jones, PhD, Juozas A. Zavadzkas, MD, Eileen I
Chadrick E. Denlinger, MD, John S. Ikonomidis, MD, PhD, Carolyn E
Bone marrow cell–induced protection of the human myocardium: Characterization and mechanism of action  Vien Khach Lai, MD, José Linares-Palomino, MD,
Michael G. Katz, MD, PhD, Elizabeth Brandon-Warner, PhD, Anthony S
P38 Mitogen Activated Protein Kinase Mediates Both Death Signaling and Functional Depression in the Heart  Meijing Wang, MD, Ben M. Tsai, MD, Mark W.
Patrick Phelan, MD, Heather E
Differential Effects of Protein Kinase C Isoform Activation in Endothelin-Mediated Myocyte Contractile Dysfunction With Cardioplegic Arrest and Reperfusion 
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
Volume 96, Issue 5, Pages (March 2009)
The evolution of ischemic spinal cord injury in function, cytoarchitecture, and inflammation and the effects of adenosine A2A receptor activation  T.
Transforming Growth Factor-β1 Mechanisms in Aortic Valve Calcification: Increased Alkaline Phosphatase and Related Events  Jocelyn N. Clark-Greuel, PhD,
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Inhibition of protein kinase Cα improves myocardial β-adrenergic receptor signaling and ventricular function in a model of myocardial preservation  Karen.
Surgery for acute type A aortic dissection on oral anticoagulants: Being the dispatcher of a 911 call  Ourania Preventza, MD, Arthur Bracey, MD  The Journal.
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
The lord of the rings  Antonio Miceli, MD, PhD 
Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation 
Downstream defects in β-adrenergic signaling and relation to myocyte contractility after cardioplegic arrest  Ward V. Houck, MD, Chadwick V. Thomas, BS,
Aprotinin Exerts Differential and Dose-Dependent Effects on Myocardial Contractility, Oxidative Stress, and Cytokine Release After Ischemia-Reperfusion 
Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology  Juan A. Crestanello, MD  The Journal of.
STAT3, Cten, and lung cancer: Simultaneous excitement and caution
Early gene expression profiles during intraoperative myocardial ischemia-reperfusion in cardiac surgery  Sara Arab, PhD, Igor E. Konstantinov, MD, PhD,
Alternative splicing in heart surgery: Lost in translation?
Pulmonary Artery Endothelial Cell Phenotypic Alterations in a Large Animal Model of Pulmonary Arteriovenous Malformations After the Glenn Shunt  Minoo.
Leora B. Balsam, MD  The Journal of Thoracic and Cardiovascular Surgery 
Edward Buratto, MBBS, Xin Tao Ye, BBiomed, Igor E
Support Your Specialty
It's not “just a shunt” but sometimes it should be…
Do we need a bibliometrician to know which way the wind is blowing?
A first start for lung transplantation?
Confusion still exists regarding postoperative delirium and its etiology after esophagectomy  Robert B. Cameron, MD  The Journal of Thoracic and Cardiovascular.
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Fueling the heart: Shifting the myocardial metabolome by targeting endothelial autophagy  Nicholas D. Andersen, MD  The Journal of Thoracic and Cardiovascular.
Instrumental variable methods in clinical research
The Ross procedure: Time to reevaluate the guidelines
Manuel J. Antunes, MD, PhD, DSc 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery  Masaki Tsukashita, MD, Akira Marui, MD, PhD, Takeshi Nishina,
Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD 
Cor triatriatum dexter: More than a simple membrane
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Ventricular assistant in restrictive cardiomyopathy: Making the right connection  Robert D.B. Jaquiss, MD  The Journal of Thoracic and Cardiovascular Surgery 
Tim C. McQuinn, MD, Rachael L
“The more things change…”: The challenges ahead
Prakash K. Pandalai, MD, Jefferson M. Lyons, MD, Jodie Y
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
Apples remain apples NO matter what
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Rachael L. Ford, BS, Ira M. Mains, BS, Ebony J. Hilton, BS, Scott T
Proactive or reactive? Best approach to limb ischemia in peripheral venoarterial extracorporeal life support  Matthew C. Black, MD, Mark S. Slaughter,
Predicting Risk of Radiation-Induced Lung Injury
Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression 
John S. Ikonomidis, MD, PhD, Charlotte R. Ivey, BS, Jason B
Gene transfection of hepatocyte growth factor attenuates the progression of cardiac remodeling in the hypertrophied heart  Keiji Iwata, MD, Yoshiki Sawa,
Presentation transcript:

Differential membrane type 1 matrix metalloproteinase substrate processing with ischemia–reperfusion: Relationship to interstitial microRNA dynamics and myocardial function  Shaina R. Eckhouse, MD, Adam W. Akerman, MS, Christina B. Logdon, MVT, J. Marshall Oelsen, BS, Elizabeth C. O’Quinn, BS, Elizabeth K. Nadeau, BS, Robert E. Stroud, MS, Rupak Mukherjee, PhD, Jeffrey A. Jones, PhD, Francis G. Spinale, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 145, Issue 1, Pages 267-277.e4 (January 2013) DOI: 10.1016/j.jtcvs.2012.09.071 Copyright © 2013 Terms and Conditions

Figure 1 A, Regional myocardial contractile function. Time-dependent rPRSW was determined in the remote (solid dot) and I/R (open triangle) regions. A time- and region-dependent difference was observed (ANOVA; F = 3.82 and F = 27.74, respectively; P < .01). B, MT1-MMP–specific fluorogenic peptide hydrolysis. A time- and region-dependent difference was observed (ANOVA; F = 9.50 and F = 3.33, respectively; P < .05). C, LTBP-1 substrate hydrolysis. A region-dependent difference was observed (ANOVA, F = 10.20, P < .05). *P < .05 versus steady state. I/R, Ischemia–reperfusion; rPRSW, regional preload recruitable stroke work; MT1-MMP, membrane type 1 matrix metalloproteinase; LTBP-1, latent transforming growth factor binding protein 1. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 267-277.e4DOI: (10.1016/j.jtcvs.2012.09.071) Copyright © 2013 Terms and Conditions

Figure 2 Activation of TGF-β signaling pathway. A, Immunoblotting total Smad2 and pSmad2 in the remote region, I/R region, and controls (n = 5). *P < .05 versus control. ‡P < .05 versus remote region. B, Myocardial mRNA levels for MMP9, MT1-MMP, LTBP1, TGF-βR1, and COL1A1 (type I collagen) in the remote region, I/R region, and controls. A region-dependent difference was observed (ANOVA; F = 4.45, F = 14.37, F = 14.62, F = 9.69, F = 6.48, respectively; all P < .05). *P < .05 versus control. IR, Ischemia–reperfusion; LTBP1, latent transforming growth factor binding protein 1; MMP9, matrix metalloproteinase 9; MT1-MMP, membrane type 1 matrix metalloproteinase; pSMAD2, phosphorylated Smad2; TGF-βR1, transforming growth factor beta receptor 1. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 267-277.e4DOI: (10.1016/j.jtcvs.2012.09.071) Copyright © 2013 Terms and Conditions

Figure 3 Interstitial miR levels. Interstitial levels of miR-133a and miR-29a were measured at steady state (gray), ischemia, and after reperfusion for the I/R (white) and remote (black) regions. Top: absolute values. Bottom: Data are depicted as a percent change from steady state. A, Interstitial miR-133a. A time-dependent difference was observed (steady-state miR-133a = 3.23 × 10−3 ± 1.15 × 10−3; ANOVA; F = 3.50; P < .05). B, Interstitial miR-29a. No change with I/R was observed (ANOVA, F = 0.39, P < .68). *P < .05 versus steady state. ‡P < .05 versus ischemia. miR, MicroRNA. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 267-277.e4DOI: (10.1016/j.jtcvs.2012.09.071) Copyright © 2013 Terms and Conditions

Figure 4 In vitro studies. A, Levels of miR-133a in conditioned medium from porcine LV fibroblast cultures (n = 3) under normoxia, hypoxia, and reoxygenation as a function of normoxia levels. B, MT1-MMP protein abundance in normal human LV fibroblast cultures (n = 3) 5 days after transduction with miR-133a or anti-miR-133a as a percent change from referent control values. *P < .05 versus steady state. ‡P < .05 versus ischemia. miR, MicroRNA; MT1-MMP, membrane type 1 matrix metalloproteinase. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 267-277.e4DOI: (10.1016/j.jtcvs.2012.09.071) Copyright © 2013 Terms and Conditions

Figure 5 Working hypothesis regarding MT1-MMP activation and changes in interstitial miR-133a with I/R. A, At steady state, MT1-MMP mRNA is translated and ultimately transported to the membrane, yielding a competent transmembrane protease. The present study identified a measurable amount of miR-133a exportation into the myocardial interstitial space, and MT1-MMP protein abundance can be regulated by miR-133a. B, With acute ischemia, interstitial MT1-MMP activity increases, likely because of increased trafficking to the membrane.1 Interstitial miR-133a levels decreased, suggesting decreased exportation and increased intracellular concentrations, where post-transcriptional regulation of its targets can occur. C, With subsequent reperfusion, interstitial MT1-MMP activity remained increased while interstitial miR-133a returned to steady-state levels within the I/R region, but exportation was not restored in the remote region. Therefore, increased miR-133a exportation within the I/R region during reperfusion (ie, a decrease in the intracellular pool of miR-133a) would relieve translational repression of miR-133a targets, including those involved with the TGF-β signaling pathway. miR, MicroRNA; MT1-MMP, membrane type 1 matrix metalloproteinase. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 267-277.e4DOI: (10.1016/j.jtcvs.2012.09.071) Copyright © 2013 Terms and Conditions